ArticleBMC medicine2014
Remembering the forgotten non-communicable diseases.
Article in BMC medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The prevalence of wholly attributable alcohol conditions in the United Kingdom hospital system: a systematic review, meta-analysis and meta-regression.Addiction (Abingdon, England) · 2019Pooled it
- Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.The American journal of gastroenterology · 2019Pooled it
- The relationship between different dimensions of alcohol use and the burden of disease-an update.Addiction (Abingdon, England) · 2017Pooled it
- Partnerships and organizational capacity drive sustainability of integrated hypertension-HIV care in primary health care in Uganda.BMC health services research · 2026Trial
- Perceived Public Health Risks Associated with Bats on a Southwest Indian Ocean Island.EcoHealth · 2026Article
- Dose-response associations of device-measured sleep regularity and duration with incident dementia in 82391 UK adults.BMC public health · 2025Article
- Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda.Wellcome open research · 2025Article
- Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers.Journal of Alzheimer's disease : JAD · 2024Article
- Economic burden of non-communicable diseases on households in Nigeria: evidence from the Nigeria living standard survey 2018-19.BMC public health · 2023Article
- Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme.Clinical and translational allergy · 2023Review
- Current and emerging therapies for alcohol-associated hepatitis.Liver research (Beijing, China) · 2023Review
- The clustering of physical health conditions and associations with co-occurring mental health problems and problematic alcohol use: a cross-sectional study.BMC psychiatry · 2023Article
- Caregivers' Perspective on the Psychological Burden of Living with Children Affected by Sickle Cell Disease in Kinshasa, the Democratic Republic of Congo.Children (Basel, Switzerland) · 2023Article
- Improving disease prevention, diagnosis, and treatment using novel bionic technologies.Bioengineering & translational medicine · 2023Review
- Bring me my alcohol!-On the continuum of pleasure and pain.Nursing philosophy : an international journal for healthcare professionals · 2023Article
- Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study.BMC health services research · 2022Article
- Incorporating neglected non-communicable diseases into the national health program-A review.Frontiers in public health · 2022Review
- Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.Journal of hepatology · 2021Observational
- Impact of body mass and alcohol consumption on all-cause and liver mortality in 240 000 adults in the United States.Drug and alcohol review · 2021Article
- Feasibility of establishing a network of community health workers to support care of people with sickle cell disease in Kumasi, Ghana.Journal of community genetics · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The forthcoming post-Millennium Development Goals era will bring about new challenges in global health. Low- and middle-income countries will have to contend with a dual burden of infectious and non-communicable diseases (NCDs). Some of these NCDs, such as neoplasms, COPD, cardiovascular diseases and diabetes, cause much health loss worldwide and are already widely recognised as doing so. However, 55% of the global NCD burden arises from other NCDs, which tend to be ignored in terms of premature mortality and quality of life reduction. Here, experts in some of these 'forgotten NCDs' review the clinical impact of these diseases along with the consequences of their ignoring their medical importance, and discuss ways in which they can be given higher global health priority in order to decrease the growing burden of disease and disability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.